These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21107303)

  • 1. Effects of sample timing and treatment on gene expression in early acute renal allograft rejection.
    Günther OP; Lin D; Balshaw RF; Ng RT; Hollander Z; Wilson-McManus J; McMaster WR; McManus BM; Keown PA;
    Transplantation; 2011 Feb; 91(3):323-9. PubMed ID: 21107303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression.
    Horwitz PA; Tsai EJ; Putt ME; Gilmore JM; Lepore JJ; Parmacek MS; Kao AC; Desai SS; Goldberg LR; Brozena SC; Jessup ML; Epstein JA; Cappola TP
    Circulation; 2004 Dec; 110(25):3815-21. PubMed ID: 15583081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional genomic analysis of peripheral blood during early acute renal allograft rejection.
    Günther OP; Balshaw RF; Scherer A; Hollander Z; Mui A; Triche TJ; Freue GC; Li G; Ng RT; Wilson-McManus J; McMaster WR; McManus BM; Keown PA;
    Transplantation; 2009 Oct; 88(7):942-51. PubMed ID: 19935467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragraft Toll-like receptor profiling in acute renal allograft rejection.
    Dessing MC; Bemelman FJ; Claessen N; Ten Berge IJ; Florquin S; Leemans JC
    Nephrol Dial Transplant; 2010 Dec; 25(12):4087-92. PubMed ID: 20876367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate is effective in preventing acute and potentially chronic renal allograft rejection.
    Michael B; Francos GC; Burke JF; Gaughan WI
    Transplant Proc; 1994 Oct; 26(5):3046-7. PubMed ID: 7940956
    [No Abstract]   [Full Text] [Related]  

  • 6. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection.
    Saint-Mezard P; Berthier CC; Zhang H; Hertig A; Kaiser S; Schumacher M; Wieczorek G; Bigaud M; Kehren J; Rondeau E; Raulf F; Marti HP
    Transpl Int; 2009 Mar; 22(3):293-302. PubMed ID: 19017305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic tubular cell death during acute renal allograft rejection.
    Wever PC; Aten J; Rentenaar RJ; Hack CE; Koopman G; Weening JJ; ten Berge IJ
    Clin Nephrol; 1998 Jan; 49(1):28-34. PubMed ID: 9491283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of early diagnose and treatment of subclinical renal allograft rejection].
    Zeng JH; Yu LX; Luo HH; Wang XC; Wang X; Fang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):697-8. PubMed ID: 16762888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute rejection in non-compliant renal allograft recipients: a distinct morphology.
    Lerut E; Kuypers DR; Verbeken E; Cleutjens J; Vlaminck H; Vanrenterghem Y; Van Damme B
    Clin Transplant; 2007; 21(3):344-51. PubMed ID: 17488383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane synthase expression in renal transplant patients with rejection.
    Ramos EL; Barri YM; Croker BP; Clapp WL; Peterson JC; Wilcox CS
    Transplantation; 1995 Feb; 59(4):490-4. PubMed ID: 7878751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection.
    Brook NR; White SA; Waller JR; Bicknell GR; Nicholson ML
    Br J Surg; 2003 Aug; 90(8):1009-14. PubMed ID: 12905557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive drug therapy and subclinical acute renal allograft rejection: impact and effect.
    Kuypers DR
    Transplantation; 2008 Apr; 85(7 Suppl):S25-30. PubMed ID: 18401259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
    Azarpira N; Aghdaie MH; Malekpour Z
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
    Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
    Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.